ARVI: rational pharmacotherapy from the standpoint of clinical pharmacology

More than 30 million cases of influenza and acute respiratory viral infections are registered in Russia every year. Therefore, the problem of adequate pharmacotherapy is turning into a real challenge. In recent years, combination drugs that are able to simultaneously affect virtually all symptoms characteristic of respiratory tract lesions from infectious diseases, have become widespread. This is achieved by combining several different mechanisms of action in one medication, while the effects complement and enhance each other. The most easy-to-use combination drugs have antipyretic, analgesic and antihistamine effects